# Assessing Uterine Cancer Risk in Lynch Syndrome Carriers Using Vaginal Self-sampling and a Health Questionnaire

> **NCT07194551** · NA · RECRUITING · sponsor: **University of British Columbia** · enrollment: 30 (estimated)

## Conditions studied

- Endometrial Cancer
- Lynch Syndrome

## Interventions

- **COMBINATION_PRODUCT:** Vaginal DNA swab, microbiome swab and pH test

## Key facts

- **NCT ID:** NCT07194551
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-29
- **Primary completion:** 2026-08
- **Final completion:** 2027-04
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07194551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07194551, "Assessing Uterine Cancer Risk in Lynch Syndrome Carriers Using Vaginal Self-sampling and a Health Questionnaire". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07194551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*